Efficacy of incobotulinumtoxinA in subjects with sialorrhea, assessed using the modified Radboud Oral Motor inventory for Parkinson’s disease (mROMP)

W. Jost,O. Michel,C. Oehlwein,J. Slawek,A. Bogucki,S. Ochudlo,M. Banach,F. Pagan,B. Flatau-Baqué,J. Csikós,A. Blitzer

TOXICON（2023）

引用 0|浏览23

暂无评分

摘要

Background: SIAXI (NCT02091739), a double-blind, randomized, Phase III study, assessed the efficacy and safety of incobotulinumtoxinA in subjects with sialorrhea. Here we report outcomes on modified Radboud Oral Motor Inventory for Parkinson’s disease (mROMP) subscales.

查看译文

关键词

lncobotulinumtoxinA,Parkinson's disease,Sialorrhea,Stroke

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要